Loading provider…
Loading provider…
Surgery Physician in Los Angeles, CA
NPI: 1003000639Primary Practice Location
RONALD REAGAN UCLA MEDICAL CENTER
757 Westwood Plz, Los Angeles, CA
Primary Employer
UCLA Cardiothoracic Surgery Associates
uclahealth.org
HQ Phone
Get MD Peyman's Phone Numberphone_androidMobile
Get MD Peyman's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2003 - 2025
CA State Medical License

American Board of Thoracic Surgery
Thoracic and Cardiac Surgery
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Thoracic Surgery - Independent
2008 - 2010
Los Angeles County-Harbor-UCLA Medical Center
Residency • Surgery
2002 - 2008
David Geffen School of Medicine at UCLA
medschool.ucla.edu
Medical School
Until 2002
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99205New patient office or other outpatient visit, typically 60 minutes | 31 | 31 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 14 | 14 |
| 3 | 33265Limited reconstruction of upper heart chamber and alteration of electrical pathway using an endoscope | 14 | 14 |
| 4 | 33268Exclusion of appendage of left upper chamber of heart performed during other procedure on chest | 13 | 13 |
Cumulative Financial Burden of Readmissions for Biliary Pancreatitis in Pregnant Women.
Authors: Erik Dutson
Publication Date: 2018-07-12
Authors: Paul Frank, Patrick Kupelian, Erik Dutson
Journal: Stud Health Technol Inform
Impact of Hospital Volume on Outcomes of Elective Pneumonectomy in the United States
Lead Sponsor: Ain Shams University
Intervention / Treatment: DIAGNOSTIC_TEST: ultrasound detection of body composition
Lead Sponsor: University of Malaya
Intervention / Treatment: DEVICE: Conventional TBA, DEVICE: 3D TBA
Lead Sponsor: Intercept Pharmaceuticals
Intervention / Treatment: DRUG: Matching Placebo, DRUG: OCA